Coherus BioSciences Inc share price logo

Coherus BioSciences Inc Share Price

NASDAQ: CHRS

Small Cap

$1.79

+0.08

(+4.97%)

as on

Coherus BioSciences Inc Stock Performance

as on April 15, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $1.71
    $1.82
    downward going graph

    4.47%

    Downside

    1.68%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $0.71
    $2.62
    downward going graph

    60.34%

    Downside

    46.13%

    Upside

    downward going graph

Coherus BioSciences Inc share price movements today

Previous Close
$1.71
Open
$1.71
Volume
1.3M
Day's Low - High
$1.71 - $1.82
52 Week Low - High
$0.71 - $2.62

Coherus BioSciences Inc Historical Returns

1 Month Return
+ 4.91 %
3 Month Return
+ 6.87 %
1 Year Return
+ 75.46 %
3 Year Return
-78.3 %
5 Year Return
-87.66 %

Coherus BioSciences Inc Stock Fundamentals & Key Indicators

Check Coherus BioSciences Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$251.8M

EPS (TTM)

-0.79

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

-0.76%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-172.5M

Revenue (TTM)

42.2M

Profit Margin

398.42%

Return On Equity TTM

33.11%

Coherus BioSciences Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Coherus BioSciences Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Coherus BioSciences Inc image
Coherus BioSciences Inc
BUY$251.8M-87.66%NA398.42%
Alnylam Pharmaceuticals Inc image
Alnylam Pharmaceuticals Inc
BUY$42.7B140.76%138.848.45%
Vertex Pharmaceuticals Inc image
Vertex Pharmaceuticals Inc
BUY$111.0B102.67%28.532.94%
BeiGene, Ltd. image
BeiGene, Ltd.
NA$35.6BNA124.865.37%
Regeneron Pharmaceuticals Inc image
Regeneron Pharmaceuticals Inc
BUY$79.2B55.14%18.0531.41%

Stock Returns calculator for Coherus BioSciences Inc Stock including INR - Dollar returns

The Coherus BioSciences Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Coherus BioSciences Inc investment value today

Current value as on today

₹1,99,620

Returns

₹99,620

(+99.62%)

Returns from Coherus BioSciences Inc Stock

₹84,536 (+84.54%)

Dollar Impact

₹15,084 (+15.08%)

Analyst Recommendation on Coherus BioSciences Inc Stock

Based on 16 analysts

BUY

81.25%

Buy

18.75%

Hold

0.00%

Sell

Based on 16 analysts, 81.25% of analysts recommend a 'BUY' rating for Coherus BioSciences Inc. Average target price of $6.75

Coherus BioSciences Inc Share Price Target

Get share price movements and forecasts by analysts on Coherus BioSciences Inc.

What analysts predicted

73.48%UPSIDE

Target Price

$6.75

Current Price

$1.79

Analyzed by

16 Analysts

Target

$6.75

Coherus BioSciences Inc target price $6.75, a slight upside of 73.48% compared to current price of $1.79. According to 16 analysts rating.

Coherus BioSciences Inc Stock’s Investor Sentiment and Interest

Search interest for Coherus BioSciences Inc Stock has decreased by -48% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-48% versus previous 30 day period

Coherus BioSciences Inc Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
74
91
2
64
70
54
7
10
11
12
Gross Profit
41
6
0
35
50
20
4
6
7
8
Operating Income
-32
-68
-67
-20
-6
-42
-45
-45
-44
-45
EBITDA
-28
-67
-63
-6
-3
-44
-44
-41
-41
-43
Interest Expense
10
10
11
5
5
5
2
2
2
2
Depreciation
0
1
1
1
1
1
1
1
0
0
Income Before Tax
-40
-79
-68
-12
-10
-50
-47
-44
-44
-46
Income Tax Expense
0
-10
1
-
-
-50
9
-342
-8
-8
Net Income
-39
-79
102
-12
-10
-50
-56
297
-35
-37
Net Profit Margin
-53.16%
-87.03%
4457.32%
-19.88%
-15.19%
-93.63%
-744.43%
2903.91%
-307.07%
-295.29%

Coherus BioSciences Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
190
1
1
356
475
326
211
257
266
42
Gross Profit
-64
-158
-1
338
438
268
140
98
149
28
Operating Income
-115
-232
-204
107
156
-263
-256
-203
-111
-181
EBITDA
-116
-225
-204
111
161
-260
-255
-193
60
-170
Interest Expense
7
9
9
17
21
22
32
40
27
9
Depreciation
-
3
3
3
2
3
3
3
5
3
Income Before Tax
-127
-238
-209
92
135
-287
-291
-238
28
-183
Income Tax Expense
0
9
4
2
3
19
34
0
28
-332
Net Income
-127
-238
-209
89
132
-287
-291
-237
28
-170
Net Profit Margin
-66.98%
-15306.56%
-13453.66%
25.23%
27.79%
-87.92%
-138.24%
-92.48%
10.68%
-403.80%

Coherus BioSciences Inc Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-79
102
-54
-10
-50
-56
297
-35
241
Operating Cash Flow
-12
-46
59
-62
28
-25
-46
-46
-19
Investing Cash Flow
35
202
27
0
0
-17
462
-67
-2
Financing Cash Flow
0
0
-187
0
0
0
-281
0
8
Change in Cash
22
156
-100
-61
28
-43
134
-113
-14

Coherus BioSciences Inc Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-238
-209
89
132
-287
-291
-237
28
168
Operating Cash Flow
-200
-159
28
154
-37
-241
-174
-20
-138
Investing Cash Flow
-4
-1
-12
-14
-138
-166
144
230
375
Financing Cash Flow
206
105
89
223
51
54
69
-186
-273
Change in Cash
1
-54
104
363
-123
-353
39
22
-37

Global Institutional Holdings in Coherus BioSciences Inc

Funds
Holdings
TANG CAPITAL MANAGEMENT LLC
1.82%
CM Management, LLC
1.4%
UBS Group AG
0.53%
Susquehanna International Group, LLP
0.26%
Barclays PLC
1.65%
See all

Insights on Coherus BioSciences Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 4 quarters, 7.59M → 12.74M (in $), with an average increase of 15.5% per quarter

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, CHRS has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 year, CHRS stock has moved up by 75.5%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 63.3% return, outperforming this stock by 141.6%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 3 quarters, 297.76M → -37.64M (in $), with an average decrease of 58.9% per quarter

About Coherus BioSciences Inc

Coherus Oncology, Inc., a biopharmaceutical company, researches, develops, and commercializes immunotherapies to treat cancer in the United States. The company develops UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte-colony stimulating factor; LOQTORZI, a novel next-generation programmed death receptor-1 inhibitor; and Casdozokitug, an investigational recombinant human immunoglobulin isotype (IgG1) monoclonal antibody targeting interleukin IL-27. It also develops CHS-114, an investigational human afucosylated IgG1 monoclonal antibody, a chemokine receptor highly expressed on Treg cells in the tumor microenvironment (TME) patients with head and neck squamous cell carcinoma. It has a collaboration agreement with Junshi Biosciences for the co-development and commercialization of toripalimab; agreements with Surface and Adimab LLC; license agreements with Bioeq AG and Genentech, Inc. and Surface and Vaccinex, Inc.; and out-licensing agreement with Novartis Institutes for Biomedical Research, Inc. and GlaxoSmithKline Intellectual Property No. 4 Limited. The company was formerly known as Coherus BioSciences, Inc. and changed its name to Coherus Oncology, Inc. in May 2025. The company was incorporated in 2010 and is based in Redwood City, California.
OrganisationCoherus BioSciences Inc
Headquarters333 Twin Dolphin Drive, Redwood City, CA, United States, 94065
IndustryBiotechnology
CEOMr. Dennis M. Lanfear
E-voting on sharesClick here to vote

Key Management of Coherus BioSciences Inc

Name

Title

Mr. Dennis M. Lanfear

Chairman, President & CEO

Mr. Bryan J. McMichael

Chief Financial Officer

Ms. Carrie Graham

Vice President of Investor Relations & Advocacy

Mr. Andy Rittenberg

Chief Legal Officer

Dr. Theresa M. Lavallee Ph.D.

Chief Development Officer & Chairman of Scientific Advisory Board

Mr. Arvind Sood

Chief Strategy & Corporate Affairs Officer

Ms. Rebecca Sunshine

Chief Human Resources Officer

Mr. Michael Chen

Senior Vice President of Commercial Analytics & Trade

Dr. Rosh Dias M.D., MRCP

Chief Medical Officer

Mr. Sameer Goregaoker

Chief Commercial Officer

FAQs

What is Coherus BioSciences Inc share price today?

Coherus BioSciences Inc share price today is $1.79 as on at the close of the market. Coherus BioSciences Inc share today touched a day high of $1.82 and a low of $1.71.

What is the 52 week high and 52 week low for Coherus BioSciences Inc share?

Coherus BioSciences Inc share touched a 52 week high of $2.62 on and a 52 week low of $0.71 on . Coherus BioSciences Inc stock price today i.e. is closed at $1.79,which is 31.57% down from its 52 week high and 152.11% up from its 52 week low.

What is Coherus BioSciences Inc's market capitalisation today?

Coherus BioSciences Inc market capitalisation is $0.00T as on .

How to invest in Coherus BioSciences Inc Stock (CHRS) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Coherus BioSciences Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Coherus BioSciences Inc Shares that will get you 0.8380 shares as per Coherus BioSciences Inc share price of $1.79 per share as on April 15, 2026 at 1:29 am IST.

What is the minimum amount required to buy Coherus BioSciences Inc Stock (CHRS) from India?

Indian investors can start investing in Coherus BioSciences Inc (CHRS) shares with as little as ₹93.082 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹930.82 in Coherus BioSciences Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Coherus BioSciences Inc share’s latest price of $1.79 as on April 15, 2026 at 1:29 am IST, you will get 5.5866 shares of Coherus BioSciences Inc. Learn more about fractional shares .

What are the returns that Coherus BioSciences Inc has given to Indian investors in the last 5 years?

Coherus BioSciences Inc stock has given -87.66% share price returns and 24.21% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?